Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06129071

Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Analgesic Effect Evaluation of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Varazdin General Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia

Detailed description

Standard pharmacological treatment for trigeminal neuralgia is often insufficient. In this setting, patients often suffer trough everyday activities and quality of life is disturbed substantially. In this prospective clinical study, analgesic effect of ultrasound (US) guided maxillary nerve block will be investigated, in order to prolong pain-free time, reduce the use of standard analgesics, as well as atypical ones (e.g. antiepileptic drugs and antidepressants). Characteristics of US guided maxillary nerve block will pain investigated: reduction of pain (decrease of VAS score), duration of pain-free period, pain level during the procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREUS guided block of maxillary nerveExtraoral ultrasound-guided block of the maxillary nerve will be performed in the examined group using an ultrasound device and local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL).

Timeline

Start date
2023-12-01
Primary completion
2024-12-31
Completion
2025-03-01
First posted
2023-11-13
Last updated
2024-04-09

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT06129071. Inclusion in this directory is not an endorsement.